Document is current
Any future updates will be listed below
-
Authors
Larue, Marion https://orcid.org/0000-0003-4810-045X
Labopin, Myriam https://orcid.org/0000-0003-4514-4748
Brissot, Eolia https://orcid.org/0000-0003-4471-418X
Alaskar, Ahmed S.
Aljurf, Mahmoud
Arat, Mutlu https://orcid.org/0000-0003-2039-8557
Baron, Frederic https://orcid.org/0000-0002-2944-3812
Bazarbachi, Ali https://orcid.org/0000-0002-7171-4997
Ciceri, Fabio https://orcid.org/0000-0003-0873-0123
Corbacioglu, Selim https://orcid.org/0000-0003-1070-8486
Dignan, Fiona L.
Kenyon, Michelle https://orcid.org/0000-0002-1859-6178
Malard, Florent
Nagler, Arnon https://orcid.org/0000-0002-0763-1265
Pagliuca, Antonio https://orcid.org/0000-0003-2519-0333
Ruggeri, Annalisa https://orcid.org/0000-0002-7261-2765
Yakoub-Agha, Ibrahim https://orcid.org/0000-0003-4524-8782
Ye, Yishan https://orcid.org/0000-0003-3706-4959
Duarte, Rafael F.
Ruutu, Tapani https://orcid.org/0000-0002-4010-8345
Carreras, Enric https://orcid.org/0000-0002-3134-9964
Peric, Zinaida
Mohty, Mohamad https://orcid.org/0000-0002-7264-808X
- License Information
-
More Information
Article History
Received: 7 June 2024
Revised: 13 September 2024
Accepted: 2 October 2024
First Online: 7 October 2024
Competing interests
: Ahmed Alaskar: Received honoraria/consultancy fees: Novartis, Abbvie, Janssen, Takeda, Kyowa Kirin, Gilead, Roche, Sanofi. Participated in company sponsored speakers bureau: Janssen, Kyowa Kirin, Sanofi. Michelle Kenyon: Received honoraria/consultancy fees: Jazz Pharmaceuticals, Sanofi, Roche, Mallinkrodt, Vertex. Speakers bureau: Jazz Pharmaceuticals, Sanofi, Pfizer.
: The IACH steering committee () approved the conduct of this survey according to standard professional practices.
